Surrey, Canada

Jaspal Singh Kang

USPTO Granted Patents = 40 

 

 

Average Co-Inventor Count = 6.5

ph-index = 12

Forward Citations = 602(Granted Patents)


Location History:

  • British Columbia, CA (2009 - 2014)
  • Burnaby, CA (2010 - 2014)
  • Surrey, CA (2007 - 2022)

Company Filing History:


Years Active: 2007-2022

Loading Chart...
Loading Chart...
Loading Chart...
40 patents (USPTO):Explore Patents

Title: Jaspal Singh Kang: A Pioneer in Antibody Innovations

Introduction

Jaspal Singh Kang is a prominent inventor based in Surrey, Canada, known for his significant contributions to the field of biotechnology. With an impressive portfolio of 40 patents, he is recognized for developing innovative solutions that enhance diagnostics and treatment methodologies for various diseases.

Latest Patents

Among his most recent patents are groundbreaking inventions in antibody technology. One such patent focuses on **targeted binding agents against B7-H1**. This patent details human monoclonal antibodies directed against B7-H1, and explores their applications in diagnostics and treatment of diseases associated with the expression of B7-H1. It further discusses hybridomas and other cell lines that express these antibodies.

Another notable patent is focused on **antibodies directed to the deletion mutants of epidermal growth factor receptor**. This invention is centered around novel antibodies, specifically those that target deletion mutants of the epidermal growth factor receptor, particularly the type III deletion mutant known as EGFRvIII. The patent covers human monoclonal antibodies related to these mutants, along with diagnostic and therapeutic formulations that utilize these antibodies and their immunoconjugates.

Career Highlights

Jaspal Singh Kang has held pivotal roles in prominent companies within the biotechnology sector. Notably, he has worked with Amgen Fremont Inc. and MedImmune Limited, where he contributed significantly to the advancement of medical therapeutics and innovations in antibody development.

Collaborations

Throughout his career, Jaspal has collaborated with notable individuals, including Ian Nevin Foltz and Larry L. Green. These partnerships have fostered a productive environment for research and development in antibody sciences.

Conclusion

Jaspal Singh Kang's innovative spirit and dedication to advancing antibody technologies have made a lasting impact on the field of biotechnology. With 40 patents to his name, his contributions continue to shape diagnostics and therapeutic approaches, providing hope for effective treatments in various medical conditions. As his work progresses, the scientific community eagerly anticipates the outcomes from his pioneering research and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…